Neuropsychological test

(redirected from NP tests)

Neuropsychological test

A test or assessment given to diagnose a brain disorder or disease.
Mentioned in: Bender-Gestalt Test
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.
References in periodicals archive ?
(18) There is one commercially available Carba NP tests (marketed as the RAPIDEC CARBA NP), and it relies on measuring imipenem hydrolysis that can change pH and result in a color change of a colorimetric pH indicator (phenol red).
(23,24) In 2016, the CLSI suggested that confirmatory tests such as the MHT, the Carba NP test and/or a molecular technique should be performed when Enterobacteriaceae isolates are associated with a suspicion of carbepenemase production based on updated carbapenem breakpoints (imipenem or meropenem or ertapenem MICs of at least [greater than or equal to] 2[micro]g/mLTable 1).
Although some biochemical tests such as the Carba NP test exhibit low sensitivity to some carbapenemases such as OXA-48, these tests are sometimes preferable given their rapidity and simplicity.
CHROMagar mSuperCARBA and RAPIDEC[R] Carba NP test for detection of carbapenemase-producing Enterobacteriaceae.
Patients do not often complain about them, and the most used NP tests do not include specific executive functioning tests.
Detecting early executive dysfunctions with specific NP tests could be useful in order to promptly enroll MS patients in adequate rehabilitation projects.
Detailed data about each NP test are reported in Table 2.
In Figure 3, for each subgroup considered, percentages of pathological scores (1.5 SD below the control mean) for every NP test are reported, and the VMD, with respect to ND, reflected a greater rate of cognitive impairment in almost every test considered.
In CHARTER participants with incidental or contributing conditions, the researchers vised standard NP tests to determine whether they had asymptomatic neurocognitive impairment (impairment that did not interfere significantly with everyday functioning), mild neurocognitive disorder, or HIV-associated dementia.
NP tests are routinely performed in the central laboratory.
On the basis of this evidence, it can only be concluded that a) VCS abnormalities are so widespread and nonspecific as to have limited usefulness as a biomarker for any particular condition (especially in the absence of industrial hygiene or environmental documentation regarding the source of exposure); and b) there is no evidence that VCS deficits have been observed in persons with current active PEAS verified by accepted, objective NP tests. Of note, passive surveillance efforts to detect PEAS have not recorded any verified cases (16) through 2000.
The ADF, DF-GLS and NP test the null of unit root whereas the KPSS tests the null of stationarity.